Organon & Co | OGN - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Bristol-Myers Squibb 9.08 0.2 2026-03
Celltrion 67.83 17.74 2025-12
Cspc Pharmaceutical 24.4 1.13 2025-12
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 66.5 5.69 2025-12
Gilead Sciences 17.7 2.07 2026-03
Glaxosmithkline 11.66 0.28 2025-12
Kangmei Pharma 3.15K 624.19 2025-06
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Merck 16.52 2.6 2026-03
Neuren Pharmaceuticals 72.14 59.86 2025-12
Novartis 17.79 1.74 2025-12
Organigram Holdings 235 224.49 2025-09
Organon & Co 3.75 0.87 2025-12
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 19.13 1.72 2026-03
Qiagen NV 20.54 0.1 2025-12
Sartorius 43.44 84.64 2026-03
Sino Biopharmaceutical 17.03 0.89 2025-06
Tilray 11.56 80.19 2025-09
Zealand Pharma A/S 5.13 0.16 2025-12